A literature search in the Web of Science Core Collection reveals that over the past decade (January 1, 2016, to January 1, 2026), annual publication output in this field has shown a gradual yet fluctuating upward trend ( Figure 1 )
The results suggested that schisandrol A, schisandrol B, schisandrin B, and schisandrin C could be used as chemical markers in the evaluation of high quality S
Combining CPAP with weight loss interventions, such as GLP-1 therapy, may reduce OSA severity, potentially decreasing the required CPAP pressure and improving comfort
SUMOUNT-4 demonstrated that continued treatment is necessary to maintain weight loss, with significant regain occurring after discontinuation
They also improve satiety , allowing you to feel full longer with smaller portions, which helps in reducing calorie intake